- Home
- Publications
- Publication Search
- Publication Details
Title
Current and Future Development in Lung Cancer Diagnosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 16, Pages 8661
Publisher
MDPI AG
Online
2021-08-12
DOI
10.3390/ijms22168661
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer
- (2021) Selina K. Wong et al. Cancers
- Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments
- (2021) Alberto Izzotti et al. Journal of Personalized Medicine
- THE MOLECULAR ANALYSIS FOR THERAPY CHOICE (NCI-MATCH) TRIAL: LESSONS for GENOMIC TRIAL DESIGN
- (2020) Keith T Flaherty et al. JNCI-Journal of the National Cancer Institute
- A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
- (2020) Lun Zhang et al. Cancers
- ELISA-based detection of Open Reading Frame protein 1 in patients at risk of developing lung cancer
- (2020) Cierra N. Sharp et al. CLINICA CHIMICA ACTA
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- (2020) Nadia Howlader et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer
- (2020) Barbara Melosky et al. ONCOLOGIST
- Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
- (2019) Ilaria Alborelli et al. Cell Death & Disease
- Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
- (2019) Sandeep Singhal et al. Cancers
- Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
- (2019) Ping-Chih Hsu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma
- (2019) Jing Ye et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Serum and blood based biomarkers for lung cancer screening: a systematic review
- (2018) Gavin C. W. Chu et al. BMC CANCER
- Liquid biopsy and its role in an advanced clinical trial for lung cancer
- (2018) Donald J Johann et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
- (2018) Douglas E. Wood et al. Journal of the National Comprehensive Cancer Network
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study.
- (2018) Charles Swanton et al. JOURNAL OF CLINICAL ONCOLOGY
- MYC expression correlates with PD-L1 expression in non-small cell lung cancer
- (2017) Eun Young Kim et al. LUNG CANCER
- Tumor molecular profiling of NSCLC patients using next generation sequencing
- (2017) Nikolaos Tsoulos et al. ONCOLOGY REPORTS
- Progress and prospects of early detection in lung cancer
- (2017) Sean Blandin Knight et al. Open Biology
- Lung Cancer Screening: Advantages, Controversies, and Applications
- (2017) Prema Nanavaty et al. Cancer Control
- The metabolomic detection of lung cancer biomarkers in sputum
- (2016) Simon J.S. Cameron et al. LUNG CANCER
- The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer
- (2016) L. Horn et al. ONCOLOGIST
- Screening for lung cancer: A systematic review and meta-analysis
- (2016) Muhammad Usman Ali et al. PREVENTIVE MEDICINE
- Human sweat metabolomics for lung cancer screening
- (2015) Mónica Calderón-Santiago et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer
- (2015) Peter J. Mazzone et al. BMC CANCER
- Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
- (2015) G. Bertolini et al. CANCER RESEARCH
- Molecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014
- (2015) Daniel Morgensztern et al. Journal of Thoracic Oncology
- The detection of EpCAM+ and EpCAM– circulating tumor cells
- (2015) Sanne de Wit et al. Scientific Reports
- Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer
- (2015) Yingrong Chen et al. Biomed Research International
- Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers
- (2014) Nanda Horeweg et al. LANCET ONCOLOGY
- Molecular sputum analysis for the diagnosis of lung cancer
- (2013) A J Hubers et al. BRITISH JOURNAL OF CANCER
- Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer
- (2013) Kyoko Okamura et al. LUNG CANCER
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- Strengths and Weaknesses of Immunotherapy for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of 12 Randomized Controlled Trials
- (2012) Juan Wang et al. PLoS One
- A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma
- (2011) M. Rotunno et al. Cancer Prevention Research
- Blood-Based Gene Expression Signatures in Non-Small Cell Lung Cancer
- (2011) T. Zander et al. CLINICAL CANCER RESEARCH
- Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients
- (2011) Andreas Keller et al. Molecular BioSystems
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience
- (2011) H. El-Osta et al. ONCOLOGIST
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy
- (2010) Sachin Kumar et al. LUNG CANCER
- Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non-Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease
- (2009) M. K. Showe et al. CANCER RESEARCH
- Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis
- (2009) Ruifeng Zhang et al. LUNG CANCER
- Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer
- (2009) Ying Xie et al. LUNG CANCER
- Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography
- (2008) Y Toyoda et al. BRITISH JOURNAL OF CANCER
- Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
- (2008) Massimiliano Paci et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started